Medicinal mushrooms: A selective overview

Alternative and Complementary Therapies

Volumn 11, Issue 3, 2005, Pages 141-145

  Meletis, Chris D ^a,b   Barker, Jason E ^c  

^a Wellness Matters   (United States)

^b National College of Natural Medicine   (United States)

^c Healthmax   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 PROPANEDIAMINE; ADENINE; ADENOSINE; CADAVERINE; CAMPASTEROL; CORDYCEPS SINENSIS EXTRACT; CORIOLUS VERSICOLOR EXTRACT; DAUCOSTEROL; DEOXYURIDINE; ERGOSTEROL; GANODERMA LUCIDUM EXTRACT; GRIFOLA FRONDOSA EXTRACT; GUANOSINE; INTERLEUKIN 1; MANNITOL; OLIGOSACCHARIDE; PLANT EXTRACT; POLYSACCHARIDE; SELENIUM; SITOSTEROL; SPERMIDINE; SPERMINE; STEROL DERIVATIVE; SUPEROXIDE DISMUTASE; THYMIDINE; TRACE ELEMENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; URACIL; URIDINE; VITAMIN;

ANTICOAGULATION; ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BLOOD GLUCOSE MONITORING; CANCER PREVENTION; CORDYCEPS; CORIOLUS VERSICOLOR; GANODERMA LUCIDUM; GRIFOLA FRONDOSA; HEART PROTECTION; IMMUNITY; LIPID PEROXIDATION; MUSHROOM; NATURAL KILLER CELL; REVIEW; T LYMPHOCYTE; VASODILATATION;

EID: 21044442547     PISSN: 10762809     EISSN: None     Source Type: Journal    
DOI: 10.1089/act.2005.11.141     Document Type: Review

References (47)

1. Chang ST. Global impact of edible and medicinal mushrooms on human welfare in the 21st century: Nongreen revolution. Int J Med Mushrooms 1999;1:1-8.
2. Chang ST, Buswell JA. Ganoderma lucidum (Curt.:Fr.) P.Karst. (Aphyllophoromycetideae)-a mushrooming medicinal mushroom. Int J Med Mushrooms 1999;1:139-148.
3. Ikekawa T, Uehara N, Maeda Y, Nakanishi M, Fukuoka F. Antitumor activity of aqueous extracts of edible mushrooms. Cancer Res 1969;29:734-735.
4. Xu WH. Water-soluble constituents of Cordyceps sinensis (Berk.) Sacc.-the nucleosides [in Chinese], Zhong Yao Tong Bao 1988;13:34-36,6S.
5. Xiao YQ. Studies on chemical constituents of Cordyceps sinensis I [in Chinese]. Zhong Yao Tong Bao 1983;8:32-33.
6. Yamaguchi Y, Kagota S, Nakamura K, Shinozuka K, Kunitomo M. Antioxidant activity of the extracts from fruiting bodies of cultured Cordyceps sinensis. Phytother Res 2000;14:647-649.
7. Jiang J, Gao Y. Summary of treatment of 37 chronic renal dysfunction patients with JinShuiBao. J Admin TCM 1995;5(suppl):23-24.
8. Chiou WF, Chang PC, Chou CJ, Chen CF. Protein constituent contributes to the hypotensive and vasorelaxant activities of Cordyceps sinensis. Life Sci 2000;66:1369-1376.
9. Zhao Y. Inhibitory effects of alcoholic extract of Cordyceps sinensis on abdominal aortic thrombus formation in rabbits [Chinese]. Zhonghua Yi Xue Za Zhi 1991;71:612-615,642.
10. Yamaguchi Y, Kagota S, Nakamura K, Shinozuka K, Kunitomo M. Inhibitory effects of water extracts from fruiting bodies of cultured Cordyceps sinensis on raised serum lipid peroxide levels and aortic cholesterol deposition in atherosclerotic mice. Phytother Res 2000; 14:650-652.
11. Chen GZ, Chen GL, Sun T, et al. Effects of Cordyceps sinensis on murine T lymphocyte subsets. Chin Med J (English) 1991;104:4-8.
12. Liu C, Lu S, Ji MR. Effects of Cordyceps sinensis (CS) on in vitro natural killer cells [in Chinese]. Chung Kuo Chung Hsi I Chieh Ho Tsa Chih 1992;12:267-269, 259.
13. Xu RH, Peng XE, Chen GZ, Chen GL. Effects of Cordyceps sinensis on natural killer activity and colony formation of B16 melanoma. Chin Med J (English) 1992;105:97-101.
14. Chen YJ, Shiao MS, Lee SS, Wang SY. Effect of Cordyceps sinensis on the proliferation and differentiation of human leukemic U937 cells. Life Sci 1997;60:2349-2359.
15. Zhu XY, Yu HY. Immunosuppressive effect of cultured Cordyceps sinensis on cellular immune response [in Chinese]. Chung Hsi I Chieh Ho Tsa Chih 1990;10:485-487,454.
16. Bok JW, Lermer L, Chilton J, et al. Antitumor sterols from the mycelia of Cordyceps sinensis. Phytochemistry 1999;51:891-8.
17. Kuo YC, Lin CY, Tsai WJ, et al. Growth inhibitors against tumor cells in Cordyceps sinensis other than cordycepin and polysaccharides. Cancer Invest 1994;12:611-615.
18. Nakamura K, Yamaguchi Y, Kagota S, et al. Inhibitory effect of Cordyceps sinensis on spontaneous liver metastasis of Lewis lung carcinoma and B16 melanoma cells in syngeneic mice. Jpn J Pharmacol 1999;79:335-341.
19. Wang SM, Lee LJ, Lin WW, Chang CM. Effects of a water-soluble extract of Cordyceps sinensis on steroidogenesis and capsular morphology of lipid droplets in cultured rat adrenocortical cells. J Cell Biochem 1998;69:483-489.
20. Kubo K, Nanba H. The effect of maitake mushrooms on liver and serum lipids. Alt Ther Health Med 1996;2:62-66.
21. Soldatos G, Cooper ME, Jandeleit-Dahm KA. Advanced-glycation end products in insulin-resistant states. Curr Hypertens Rep 2005; 7:96-102.
22. Konno S, Tortorelis DG, Fullerton SA, et al. A possible hypoglycaemic effect of maitake mushroom on Type 2 diabetic patients. Diabet Med 2001;18:1010.
23. Kubo K, Aoki H, Nanba H. Anti-diabetic activity present in the fruit body of Grifola frondosa (Maitake): I. Biol Pharm Bull 1994;17:1106-1110.
24. Kabir Y, Kimura S. Dietary mushrooms reduce blood pressure in spontaneously hypertensive rats (SHR). J Nutr Sci Vitaminol (Tokyo) 1989;35:91-94.
25. Kabir Y, Yamaguchi M, Kimura S. Effect of shiitake (Lentinus edodes) and maitake (Grifola frondosa) mushrooms on blood pressure and plasma lipids of spontaneously hypertensive rats. J Nutr Sci Vitaminol (Tokyo) 1987;33:341-346.
26. Ross GD, Vetvicka V, Yan J, et al. Therapeutic intervention with complement and beta-glucan in cancer. Immunopharmacology 1999;42:61-74.
27. Adachi K, Nanba H, Kuroda H. Potentiation of host-mediated antitumor activity in mice by beta-glucan obtained from Grifola frondosa (maitake). Chem Pharm Bull (Tokyo) 1987;35:262-270.
28. Nanba H. Activity of maitake D-fraction to inhibit carcinogenesis and metastasis. Ann NY Acad Sci 1995;768:243-245.
29. Nanba H, Kubo K. Effect of Maitake D-fraction on cancer prevention. Ann NY Acad Sci 1997;833:204-207.
30. Jones K. Reishi: Ancient Herb for Modern Times. Issaquah, WA: Sylvan Press, 1990:6.
31. Shu HY. Oriental Materia Medica: A Concise Guide. Palos Verdes: Oriental Healing Arts Press, 1986:640-641.
32. Zhu M, Chang Q, Wong LK, Chong FS, Li RC. Triterpene antioxidants from Ganoderma lucidum. Phytother Res. 1999;13:529-531.
33. LingZhi. In: Chang H-M, But RP-H, eds. Pharmacology and Application of Chinese Materia Medica, vol. 1. Singapore: World Scientific Publishing Co. Ltd. 1986:642-653.
34. Morigiwa A, Kitabatake K, Fujimoto Y, Ikekawa N. Angiotension converting enzyme-inhibitory triterpenes from Ganoderma lucidum. Chem Pharmaceutical Bull 1986;34:3025-3028.
35. Tao J, Feng KY. Experimental and clinical studies on inhibitory effect of Ganoderma lucidum on platelet aggregation. J Tongji Med Univ 1990;10:240-243.
36. Yoshiaki S, et al. Structures and antitumor activities of the polysaccharides isolated from fruiting body and the growing culture of mycelium of Ganoderma lucidum. Agric Biol Chem 1985;49:2641-2653.
37. Kino K, Yamashita A, Yamaoka K, Watanabe J, Tanaka S, Ko K, Shimizu K, Tsunoo H. Isolation and characterization of a new immunomodulatory protein, Ling Zhi-S (LZ-8), from Ganoderma lucidum. J Biol Chem 1989;264:472-478.
38. Wang SY, et al. The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophage and T lymphocytes. Int J Cancer 1997;70:699-705.
39. Mau JL, et al. Antioxidant properties of several medicinal mushrooms. J Agric Food Chem 2002;50:6072-6077.
40. Nakamura K, et al. Susceptibility of natural killer (NK) cells to reactive oxygen species (ROS) and their restoration by the mimics of superoxide dismutase (SOD) Cancer Biother Radiopharm 1998;13:275-290.
41. Chu KK, et al. Coriolus versicolor: A medicinal mushroom with promising immunotherapeutic values. J Clin Pharmacol 2002;42:976-984.
42. Dong Y, Yang MM, Kwan CY. In vitro inhibition of proliferation of HL-60 cells by tetrandrine and Coriolus versicolor peptide derived from Chinese medicinal herbs. Life Sci 1997;60:PL135-140.
43. Suto T, Fukuda S, Moriya N, et al. Clinical study of biological response modifiers as maintenance therapy for hepatocellular carcinoma. Cancer Chemother Pharmacol 1994;33(suppl)S145-S148.
44. Nakazato H, Koike A, Saji S, et al. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer: Study Group of Immunochemotherapy with PSK for Gastric Cancer. Lancet 1994;343:1122-1126.
45. Ng TB. A review of research on the protein-bound polysaccharide (polysaccharopeptide, PSP) from the mushroom Coriolus versicolor (Basidiomycetes: Polyporaceae). Gen Pharmacol 1998;30:1-4.
46. Collins RA, Ng TB. Polysaccharopeptide from Coriolus versicoior has potential for use against human immunodeficiency virus type 1 infection. Life Sci 1997;60:PL383-387.
47. Tochikura TS, Nakashima H, Hirose K, et al. A biological response modifier, PSK, inhibits human immunodeficiency virus infection in vitro. Biochem Biophys Res Commun 1987;148:726-733.